187 related articles for article (PubMed ID: 31561981)
1. Renal denervation for the treatment of resistant hypertension in Spain. The Flex-Spyral Registry.
Rodriguez-Leor O; Segura J; García Donaire JA; Gutiérrez-Ibañes E; Oliveras A; Mediavilla JD; Serrador A; Prado JC; Nuñez-Gil I; Díez-Delhoyo F; Clarà Velasco A; Jaén Águila F; Amat-Santos I; Bayes-Genis A; Troya Saborido MI
Rev Esp Cardiol (Engl Ed); 2020 Aug; 73(8):615-622. PubMed ID: 31561981
[TBL] [Abstract][Full Text] [Related]
2. Blood pressure response to catheter-based renal sympathetic denervation in severe resistant hypertension: data from the Greek Renal Denervation Registry.
Tsioufis C; Ziakas A; Dimitriadis K; Davlouros P; Marketou M; Kasiakogias A; Thomopoulos C; Petroglou D; Tsiachris D; Doumas M; Skalidis E; Karvounis C; Alexopoulos D; Vardas P; Kallikazaros I; Stefanadis C; Papademetriou V; Tousoulis D
Clin Res Cardiol; 2017 May; 106(5):322-330. PubMed ID: 27957627
[TBL] [Abstract][Full Text] [Related]
3. Catheter-based ultrasound renal denervation in patients with resistant hypertension: the randomized, controlled REQUIRE trial.
Kario K; Yokoi Y; Okamura K; Fujihara M; Ogoyama Y; Yamamoto E; Urata H; Cho JM; Kim CJ; Choi SH; Shinohara K; Mukai Y; Ikemoto T; Nakamura M; Seki S; Matoba S; Shibata Y; Sugawara S; Yumoto K; Tamura K; Yoshihara F; Nakamura S; Kang WC; Shibasaki T; Dote K; Yokoi H; Matsuo A; Fujita H; Takahashi T; Kang HJ; Sakata Y; Horie K; Inoue N; Sasaki KI; Ueno T; Tomita H; Morino Y; Nojima Y; Kim CJ; Matsumoto T; Kai H; Nanto S
Hypertens Res; 2022 Feb; 45(2):221-231. PubMed ID: 34654905
[TBL] [Abstract][Full Text] [Related]
4. Renal sympathetic denervation in Sweden: a report from the Swedish registry for renal denervation.
Völz S; Spaak J; Elf J; Jägrén C; Lundin C; Stenborg A; Andersson J; Rundqvist B; Kahan T; Andersson B
J Hypertens; 2018 Jan; 36(1):151-158. PubMed ID: 29210862
[TBL] [Abstract][Full Text] [Related]
5. Randomized comparison of renal denervation versus intensified pharmacotherapy including spironolactone in true-resistant hypertension: six-month results from the Prague-15 study.
Rosa J; Widimský P; Toušek P; Petrák O; Čurila K; Waldauf P; Bednář F; Zelinka T; Holaj R; Štrauch B; Šomlóová Z; Táborský M; Václavík J; Kociánová E; Branny M; Nykl I; Jiravský O; Widimský J
Hypertension; 2015 Feb; 65(2):407-13. PubMed ID: 25421981
[TBL] [Abstract][Full Text] [Related]
6. Blood pressure reductions following catheter-based renal denervation are not related to improvements in adherence to antihypertensive drugs measured by urine/plasma toxicological analysis.
Ewen S; Meyer MR; Cremers B; Laufs U; Helfer AG; Linz D; Kindermann I; Ukena C; Burnier M; Wagenpfeil S; Maurer HH; Böhm M; Mahfoud F
Clin Res Cardiol; 2015 Dec; 104(12):1097-105. PubMed ID: 26306594
[TBL] [Abstract][Full Text] [Related]
7. Effect of renal denervation on blood pressure in the presence of antihypertensive drugs: 6-month efficacy and safety results from the SPYRAL HTN-ON MED proof-of-concept randomised trial.
Kandzari DE; Böhm M; Mahfoud F; Townsend RR; Weber MA; Pocock S; Tsioufis K; Tousoulis D; Choi JW; East C; Brar S; Cohen SA; Fahy M; Pilcher G; Kario K;
Lancet; 2018 Jun; 391(10137):2346-2355. PubMed ID: 29803589
[TBL] [Abstract][Full Text] [Related]
8. Organ damage changes in patients with resistant hypertension randomized to renal denervation or spironolactone: The DENERVHTA (Denervación en Hipertensión Arterial) study.
Oliveras A; Armario P; Sans L; Clarà A; Vázquez S; Molina L; Pareja J; de la Sierra A; Pascual J
J Clin Hypertens (Greenwich); 2018 Jan; 20(1):69-75. PubMed ID: 29316186
[TBL] [Abstract][Full Text] [Related]
9. Insights on safety and efficacy of renal artery denervation for uncontrolled-resistant hypertension in a high risk population with chronic kidney disease: first Italian real-world experience.
Marin F; Fezzi S; Gambaro A; Ederle F; Castaldi G; Widmann M; Gangemi C; Ferrero V; Pesarini G; Pighi M; Ribichini FL
J Nephrol; 2021 Oct; 34(5):1445-1455. PubMed ID: 33481223
[TBL] [Abstract][Full Text] [Related]
10. Renal denervation in resistant hypertension treatment.
Orekhov AU; Sabitov YT; Karazhanova LK
Bratisl Lek Listy; 2022; 123(10):710-715. PubMed ID: 35913004
[TBL] [Abstract][Full Text] [Related]
11. Effects of renal sympathetic denervation on blood pressure and glycaemic control in patients with true resistant hypertension: results of Polish Renal Denervation Registry (RDN-POL Registry).
Kądziela J; Prejbisz A; Kostka-Jeziorny K; Dudek D; Narkiewicz K; Sadowski J; Lekston A; Gziut A; Więcek A; Buszman P; Kleinrok A; Kochman J; Czarnecka D; Januszewicz A; Witkowski A
Kardiol Pol; 2016; 74(9):961-8. PubMed ID: 27160171
[TBL] [Abstract][Full Text] [Related]
12. Long-term outcomes after renal denervation in an Asian population: results from the Global SYMPLICITY Registry in South Korea (GSR Korea).
Kim BK; Kim HS; Park SJ; Park CG; Seung KB; Gwon HC; Choi DJ; Ahn TH; Kim CJ; Kwon HM; Shen C; Jang Y
Hypertens Res; 2021 Sep; 44(9):1099-1104. PubMed ID: 34145423
[TBL] [Abstract][Full Text] [Related]
13. Catheter-based renal denervation in patients with uncontrolled hypertension in the absence of antihypertensive medications (SPYRAL HTN-OFF MED): a randomised, sham-controlled, proof-of-concept trial.
Townsend RR; Mahfoud F; Kandzari DE; Kario K; Pocock S; Weber MA; Ewen S; Tsioufis K; Tousoulis D; Sharp ASP; Watkinson AF; Schmieder RE; Schmid A; Choi JW; East C; Walton A; Hopper I; Cohen DL; Wilensky R; Lee DP; Ma A; Devireddy CM; Lea JP; Lurz PC; Fengler K; Davies J; Chapman N; Cohen SA; DeBruin V; Fahy M; Jones DE; Rothman M; Böhm M;
Lancet; 2017 Nov; 390(10108):2160-2170. PubMed ID: 28859944
[TBL] [Abstract][Full Text] [Related]
14. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial.
; Esler MD; Krum H; Sobotka PA; Schlaich MP; Schmieder RE; Böhm M
Lancet; 2010 Dec; 376(9756):1903-9. PubMed ID: 21093036
[TBL] [Abstract][Full Text] [Related]
15. Effects of renal denervation on blood pressures in patients with hypertension: a systematic review and meta-analysis of randomized sham-controlled trials.
Ogoyama Y; Tada K; Abe M; Nanto S; Shibata H; Mukoyama M; Kai H; Arima H; Kario K
Hypertens Res; 2022 Feb; 45(2):210-220. PubMed ID: 34657140
[TBL] [Abstract][Full Text] [Related]
16. [Renal denervation a treatment for resistant hypertension: a French experience].
Benamer H; Mylotte D; Garcia-Alonso C; Unterseeh T; Garot P; Louvard Y; Lefevre T; Morice MC;
Ann Cardiol Angeiol (Paris); 2013 Dec; 62(6):384-91. PubMed ID: 24182849
[TBL] [Abstract][Full Text] [Related]
17. Renal denervation in patients with end-stage renal disease and resistant hypertension on long-term haemodialysis.
Scalise F; Sole A; Singh G; Sorropago A; Sorropago G; Ballabeni C; Maccario M; Vettoretti S; Grassi G; Mancia G
J Hypertens; 2020 May; 38(5):936-942. PubMed ID: 31990900
[TBL] [Abstract][Full Text] [Related]
18. Effect of catheter-based renal sympathetic denervation on 24-h ambulatory blood pressure in patients with resistant hypertension.
Völz S; Andersson B; Manhem K; Haraldsson I; Rundqvist B
Blood Press; 2014 Aug; 23(4):228-32. PubMed ID: 24432803
[TBL] [Abstract][Full Text] [Related]
19. Renal denervation using an irrigated catheter in patients with resistant hypertension: a promising strategy?
Armaganijan L; Staico R; Moraes A; Abizaid A; Moreira D; Amodeo C; Sousa M; Borelli F; Armaganijan D; Sousa JE; Sousa A
Arq Bras Cardiol; 2014 Apr; 102(4):355-63. PubMed ID: 24652055
[TBL] [Abstract][Full Text] [Related]
20. Reduced effect of percutaneous renal denervation on blood pressure in patients with isolated systolic hypertension.
Ewen S; Ukena C; Linz D; Kindermann I; Cremers B; Laufs U; Wagenpfeil S; Schmieder RE; Böhm M; Mahfoud F
Hypertension; 2015 Jan; 65(1):193-9. PubMed ID: 25331843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
